FEATURED, Health care economics, News
"It's the prices, stupid" Why does the U. S. spend so much on health care?
As noted in a recent article in the New York Times (NY Times), the United States spends about twice as much for health care as a percentage of the economy as pe...
Gene transfer using a viral vector: the future is now
In the December 9th, 2017 edition of the New England Journal of Medicine researchers from England used a adenovirus vector encoded with a wild-type factor VIII ...
Your De-Identified DNA Can Identify You....
Genetic testing is here, is not going to get less common and we will all have our DNA mapped by 2020....but I could be wrong - it could be 2018. However, when ...
Two Years of Adjuvant Therapy for Patients with Her2+ Cancer, Do I Hear Three?
Neratinib (oral tyrosine kinase inhibitor - dual blockade of HER2 and EGFR kinases) for 1 year AFTER neo/adjuvant chemo/trastuzumab - so 2 years total of therap...
CRISPR Slowly Advances into the Clinic
An article by Susan Jenks appears in a recent edition of the Journal of the National Cancer Institute (JNCI 2017;109 (10)) The articled is titled “CRISPR Slowly...
New SERM, New era??
A new SERM - Z-Endoxifen has shown promise in a phase 1 study of 38 pts. Stable disease >6m or partial responses were seen in 26% of patients and the maximu...
Disruptive Technology Alert: FDA-cleared Smartphone Ultrasound
A high quality, all-body, smartphone-based, PACS-compatible ultrasound probe for $2,ooo. This particular tech development may soon appear in the dictionary unde...
From the Forum: Not Risk Factors for Lymphedema: Blood draws, IVs, BPs, Exercise, Air travel
Risk factors for Lymphedema: High BMI, Axillary dissection, Chemotherapy (esp taxanes), Radiation, Infection Not Risk Factors for Lymphedema: blood draws, IVs, ...
Cureus Competition Winner Announced!
In 2016, Cureus and TME sponsored a case report research competition called: Exceptional Responders in Breast cancer. We sought challenging cases where breast c...
